![]() Phantana-angkool A, Voci AE, Warren YE, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer. Sentinel lymph node metastasis in microinvasive breast cancer. ![]() Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: retrospective observational study. īertozzi S, Cedolini C, Londero AP, et al. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ. Magnoni F, Massari G, Santomauro G, et al. Microinvasive breast carcinoma: an analysis from ten Senonetwork Italia breast centres. Ĭostarelli L, Cianchetti E, Corsi F, et al. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma. Hanna MG, Jaffer S, Bleiweiss IJ, Nayak A. Sentinel lymph node biopsy in patients with microinvasive breast cancer: a systematic review and meta-analysis. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study. Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Clinicopathologic analysis of a large series of microinvasive breast cancers. Results of a large single-institution series. Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Orzalesi L, Casella D, Criscenti V, et al. This information can factor into shared decision-making for SLNB in patients with DCISM. Tumor grade was identified as influencing the risk of SLN metastases. The rate of sentinel node metastases in DCISM is low at only 2.9% in this national study. Age and receptor status of the tumor did not have a clear association in predicting SLN metastases. Low/intermediate grade tumors were associated with decreased SLN metastasis (OR 0.50, CI 0.28–0.92). Of these, 76 (2.9%) were found to have sentinel lymph node metastases on final pathology. Our cohort comprised of 2609 patients with pT1mi who underwent SLNB. Multivariable regression analysis was performed to determine associations between sentinel lymph node metastasis and relevant clinical variables. The National Cancer Database was used to select patients with DCISM (pT1mi), diagnosed from 2012 to 2015, who underwent SLNB. The aim of the present study was to identify risk factors for nodal disease in patients with DCISM, which can help develop a selective approach to SLNB in this patient population. Reports in the literature differ on the utility and necessity of sentinel lymph node biopsy (SLNB) for DCISM. N Engl J Med 1999 340: 1455–61.Microinvasive ductal carcinoma (DCISM), defined as DCIS with a focus of invasive carcinoma ≤ 1 mm, can be managed similarly to pure DCIS however, management of the axilla in DCISM has been a subject of debate. The influence of margin width on local control in patients with ductal carcinoma in situ (DCIS) of the breast. Silverstein MJ, Lagios MD, Groshen S, et al. Axillary metastases with DCIS: is the glass half empty or half full? Ann Surg Oncol 2000 7: 631–33. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: First results of EORTC randomized phase III trial 10853. Fifteen year results of breast conserving surgery and definitive breast irradiation for treatment of ductal carcinoma in situ of the breast. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Outcome After Invasive Local Recurrence in Patients with Ductal Carcinoma in Situ of the Breast. Silverstein MJ, Lagios MD, Martino S, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failure. Lagios MD, Westdahl PR, Margolin FR, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. Is it indicated in patients with high-risk DCIS and DCIS with microinvasion? Ann Surg Oncol 2000 7: 636–42.īraun S, Pantel K, Muller P, et al. Klauber-DeMore N, Tan LK, Liberman L, et al. ![]() Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer 1987 59: 1819–24. Silverstein MJ, Rosser RJ, Gierson ED, et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. ![]() A Preliminary Study, Cancer, 1999 86: 990–96.Ĭote RJ, Peterson HF, Chaiwun B, et al. Occult metastases in sentinel lymph nodes of patients with early stage breast carcinoma. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |